Lamisil 1% w/w Cream

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

지금 구매하세요

Download 제품 특성 요약 (SPC)
30-05-2014

유효 성분:

TERBINAFINE HYDROCHLORIDE

제공처:

Imbat Limited

ATC 코드:

D01AE; D01AE15

INN (국제 이름):

TERBINAFINE HYDROCHLORIDE

복용량:

1 percent weight/weight

약제 형태:

Cream

처방전 유형:

Product subject to prescription which may be renewed (B)

치료 영역:

Other antifungals for topical use; terbinafine

승인 상태:

Authorised

승인 날짜:

2011-09-23

제품 특성 요약

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Lamisil 1% w/w Cream
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Terbinafine hydrochloride 1% w/w.
Excipients: Each gram of cream contains 40mg cetyl alcohol and 40mg
stearyl alcohol
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Cream.
_Product imported from Greece_
White, smooth to almost smooth, glossy cream.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Fungal infections of the skin caused by_ Trichophyton_ (e.g._
T.rubrum, T. mentagrophytes, T. verrucosum, T. violaceum_),
_Microsporum canis_ and_ Epidermophyton floccosum._
Yeast infections of the skin, principally those caused by the genus_
Candida_ (e.g._ C_._albicans_).
Pityriasis (tinea) versicolor due to_ Pityrosporum orbiculare_ (also
known as_ Malassezia furfur_).
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
LAMISIL can be applied once or twice daily.
Cleanse and dry the affected areas thoroughly before application of
Lamisil.
Apply the cream to the affected skin and surrounding area in a thin
layer and rub in lightly.
In the case of
intertriginous infections (submammary,
interdigital,
intergluteal,
inguinal) the application may be covered with a gauze
strip, especially at night.
The likely durations of treatment are as follows:
In the case of intertriginous infections (submammary, interdigital,
intergluteal, inguinal), the application may be covered
with a gauze strip, especially at night.
Relief of clinical symptoms usually occurs within a few days.
Irregular use or premature discontinuation of treatment
carries the risk of recurrence.
If there are no signs of improvement after two weeks the diagnosis
should be verified.
_Use in the elderly_
There is no evidence to suggest that elderly patients require
different dosages or experience side effects different to those
of younger patients.
Tinea pedis:
1 week
Tinea corporis, cruris:
1 to 2 weeks
Cutaneous candidiasis:
1 to 2 weeks
Pityriasis versicolor:
2 weeks
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___

                                
                                전체 문서 읽기
                                
                            

이 제품과 관련된 검색 알림